Managing Hypertension in Patients Aged 75 Years and Older

被引:0
作者
Yogita Rochlani
Mohammed Hasan Khan
Wilbert S. Aronow
机构
[1] Westchester Medical Center and New York Medical College,Cardiology Division, Department of Medicine
来源
Current Hypertension Reports | 2017年 / 19卷
关键词
Hypertension; Elderly; Blood pressure; Antihypertensive drug therapy;
D O I
暂无
中图分类号
学科分类号
摘要
On the basis of the available data, we would diagnose a normal blood pressure in elderly persons including those 75 years of age and older if the blood pressure was below 120/80 mmHg. We would diagnose hypertension in elderly persons including those aged 75 years and older if the systolic blood pressure was 130 mmHg and higher or if the diastolic blood pressure was 80 mmHg and higher. We would treat these elderly patients with hypertension to a blood pressure goal of less than 130/80 mmHg if the blood pressure was obtained by automated blood pressure monitoring in a quiet room. We would consider treating high-risk persons aged 75 years and older to a blood pressure goal of less than 120/80 mmHg if they were carefully monitored for serious adverse events. If the blood pressure is more than 20/10 mmHg above the goal blood pressure, we would initiate antihypertensive drug therapy with two antihypertensive drugs. The initial drug of choice for the treatment of hypertension in adults aged 75 years and older should be based on co-morbidities, co-incidental indications, tolerability, and cost.
引用
收藏
相关论文
共 234 条
  • [1] Zhou B(2017)Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants Lancet 389 37-55
  • [2] Bentham J(2016)Isolated systolic hypertension: an update after SPRINT Am J Med 129 1251-1258
  • [3] Di Cesare M(2011)ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Developed in collaborationwith the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension J Am Coll Cardiol 57 203
  • [4] Bixby H(1991)Isolated systolic hypertension in the elderly: implications of Systolic Hypertension in the Elderly Program (SHEP) for clinical practice and for the ongoing trials J Hum Hypertens 5 469-474
  • [5] Danaei G(2008)Treatment of hypertension in patients 80 years of age or older N Engl J Med 358 1887-1898
  • [6] Cowan MJ(2015)A randomized trial of intensive versus standard blood-pressure control N Engl J Med 373 2103-2116
  • [7] Bavishi C(2016)Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years. A randomized clinical trial JAMA 315 2673-2682
  • [8] Goel S(2016)Global disparities of hypertension prevalence and control clinical perspective Circulation 134 441-450
  • [9] Messerli FH(2002)Age-specific relevance of usual blood pressure to vascular mortalty: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 1903-1913
  • [10] Aronow WS(1991)Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP) JAMA 265 3255-3264